176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.94%
Revenue growth at 50-75% of MRVL's 29.27%. Martin Whitman would worry about competitiveness or product relevance.
16.15%
Positive gross profit growth while MRVL is negative. John Neff would see a clear operational edge over the competitor.
24.95%
Positive EBIT growth while MRVL is negative. John Neff might see a substantial edge in operational management.
24.95%
Positive operating income growth while MRVL is negative. John Neff might view this as a competitive edge in operations.
24.16%
Positive net income growth while MRVL is negative. John Neff might see a big relative performance advantage.
23.38%
Positive EPS growth while MRVL is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
23.68%
Positive diluted EPS growth while MRVL is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.36%
Share reduction more than 1.5x MRVL's 18.41%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.16%
Diluted share reduction more than 1.5x MRVL's 18.42%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.65%
Dividend growth under 50% of MRVL's 2.72%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
43.12%
OCF growth under 50% of MRVL's 1718.03%. Michael Burry might suspect questionable revenue recognition or rising costs.
58.57%
FCF growth under 50% of MRVL's 583.44%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
517.62%
Positive 10Y revenue/share CAGR while MRVL is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
290.42%
5Y revenue/share CAGR above 1.5x MRVL's 6.94%. David Dodd would look for consistent product or market expansions fueling outperformance.
102.92%
3Y revenue/share CAGR above 1.5x MRVL's 8.77%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
3054.94%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
1148.88%
5Y OCF/share CAGR above 1.5x MRVL's 133.28%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
186.10%
3Y OCF/share CAGR 1.25-1.5x MRVL's 141.20%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
1411.18%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
703.97%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
110.00%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
453.02%
10Y equity/share CAGR above 1.5x MRVL's 117.37%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
304.44%
5Y equity/share CAGR above 1.5x MRVL's 120.69%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
134.17%
3Y equity/share CAGR above 1.5x MRVL's 29.35%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
38.19%
5Y dividend/share CAGR above 1.5x MRVL's 0.14%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
7.02%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
18.58%
AR growth well above MRVL's 13.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.12%
We show growth while MRVL is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
25.50%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
12.23%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
63.60%
We have some new debt while MRVL reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
7.98%
R&D dropping or stable vs. MRVL's 28.29%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
1.15%
SG&A declining or stable vs. MRVL's 28.64%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.